Researchers are excited about this new drug, a novel dual agonist showing promising data in clinical trials for size reduction . It acts by impacting several hormones : GLP-1 and GIP, that , when activated , support regulate cravings and improve metabolism . Preliminary observations demonstrate noteworthy body management and possible advantages … Read More